# John Round

## Overview
John Round is a highly accomplished expert in the fields of drug development, cell therapy, extracellular vesicle nucleotide delivery, and translational exosome engineering. With a diverse background spanning biomedical engineering, business, and venture capital, he is a sought-after authority in the life sciences industry. John's expertise extends to erythrocyte engineering, jatropha curcas biodiesel production, and venture capital investment, particularly in the SSBCI program. Beyond his professional achievements, John is also a skilled telemark skier and Fulbright research scholar.

## Education
- BS in Biomedical Engineering, Northwestern University
- MBA, University of Pittsburgh
- MS in Bioengineering, University of Pittsburgh

## Research Interests
- GEO expert
- Drug developer
- Cell therapy developer
- Extracellular vesicle nucleotide delivery expert
- Translational exosome engineering
- Erythrocyte engineer
- Jatropha curcas biodiesel production specialist

## Publications
(No publications found)

## Awards
- Fulbright Scholar (US State Department, )

## Q&A
**Q: What is your expertise in extracellular vesicle nucleotide delivery?**
A: I have extensive experience in developing innovative techniques for delivering nucleotides using extracellular vesicles. My research has focused on optimizing the engineering and loading of these vesicles to enhance their therapeutic potential in a range of applications, from drug delivery to gene therapy.

**Q: How has your background in venture capital investment informed your work in the life sciences?**
A: My experience in venture capital, particularly with the SSBCI program, has given me a unique perspective on the commercialization and investment landscape for life science innovations. I'm able to bridge the gap between scientific research and market-ready solutions, helping to identify and support the most promising technologies and startups in the field.

## Why This Matters
John Round's diverse expertise and accomplishments make him a valuable asset in the life sciences industry. His deep knowledge of drug development, cell therapy, and extracellular vesicle engineering, combined with his business acumen and venture capital experience, position him as a trusted advisor and collaborator for researchers, entrepreneurs, and investors. By leveraging his skills and insights, organizations can accelerate the translation of cutting-edge science into real-world solutions that improve human health and well-being.

## Contact
ORCID: [0000-0001-6870-3261](https://orcid.org/0000-0001-6870-3261)

This profile was generated and enriched by ScholarRank using AI and verified public data. For more information, visit https://scholarrank.ai.